Our pain management study teams here at SCOPE International have experience in conducting a wide variety of clinical studies including mild, severe, acute, chronic and breakthrough pain indications. With a full range of services and profound experience, we are able to define a strong development plan for your drug, device, or combination product and oversee the study from concept to delivery.
SCOPE International has successfully conducted more than 54 pain studies involving more than 1,600 clinical sites and 12,000 patients in both adult and pediatric pain indications. We have established networks of investigators across a variety of pain indications; by maintaining close relationships with neurologists, pain clinics, palliative specialists, surgeons, anesthesiologists, general practitioners, and key opinion leaders (KOL), we are able to provide rapid and accurate feasibility estimates at outset. We build upon our well-established relationships with experienced, qualified and motivated sites to ensure the success of your trial.
Your program will be monitored by experienced clinical research associates, project managers, and medical monitors who are familiar with the specific nuances of these types of studies. Moreover, because pain is a subjective experience, the choice of an adequate instrument to measure the primary endpoint is essential to demonstrating the efficacy of an analgesic. Our staff can advise on selection of appropriate, well-defined and guideline-conforming tools including those suitable for use in the setting of a clinical trial to measure change over time. These include all the commonly utilised tools such as:
•_Brief Pain Inventory
•_MPI, Mood and Symptom Questionnaire
•_West Haven Yale Multidimensional Pain Inventory
•_Neurological Impairment Set
•_Numeric Rating Scales
•_Visual Analog Scales